F-group (family)
2003.1.5.55 PrmA
Ligands and drugs
967
Member domains
359
with ligand contacts (≤ 4 Å)
37.1% of members
327
with DrugDomain annotations
33.8% of members
166
with a DrugBank compound
17.2% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2003.1.5.55 belongs to X-group 2003 Rossmann-like, which binds 8.9 ligand superclasses per 20 proteins, broader than 78% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB01752 | SAH | S-adenosyl-L-homocysteine | 75 |
| DB01910 | SFG | Sinefungin | 34 |
| DB01749 | DXE | 1,2-Dimethoxyethane | 25 |
| DB02935 | M2M | Diglyme | 12 |
| DB00118 | SAM | Ademetionine | 7 |
| DB02580 | PG6 | Pentaglyme | 3 |
| DB02676 | B3P | 2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol | 3 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| SAH | S-ADENOSYL-L-HOMOCYSTEINE | 77 |
| SFG | SINEFUNGIN | 34 |
| DXE | 1,2-DIMETHOXYETHANE | 29 |
| QVR | (2~{R},3~{R},4~{S},5~{R})-2-(6-aminopurin-9-yl)-5-[(~{E})-prop-1-enyl]oxolane-3,4-diol | 22 |
| SAO | 5'-S-[(3S)-3-azaniumyl-3-carboxypropyl]-5'-thioadenosine | 14 |
| UNX | UNKNOWN ATOM OR ION | 12 |
| M2M | 1-METHOXY-2-(2-METHOXYETHOXY)ETHANE | 11 |
| KXW | (2~{S})-4-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-[3-(pyridin-2-ylamino)propyl]amino]-2-azanyl-butanoic acid | 8 |
| 2MM | N,N-dimethyl-L-methionine | 7 |
| SAM | S-ADENOSYLMETHIONINE | 7 |
| 8ZB | (2~{R},3~{R},4~{S},5~{R})-2-(6-aminopurin-9-yl)-5-propyl-oxolane-3,4-diol | 6 |
| FTG | (2S,5S)-2-amino-6-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]-5-[(benzylamino)methyl]-N-[2-(4-hydroxyphenyl)ethyl]hexanamide | 6 |
| CL | CHLORIDE ION | 5 |
| 4IK | (2S,5S)-2,6-diamino-5-{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl}hexanoic acid | 4 |
| 4R7 | methyl 6-[4-[[N-[2-[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]ethyl]carbamimidoyl]amino]butylcarbamoylamino]-4-oxidanyl-naphthalene-2-carboxylate | 4 |
| 5N5 | 5'-amino-5'-deoxyadenosine | 4 |
| 6CX | 5'-{[(3S)-3-amino-3-carboxypropyl][(1H-imidazol-4-yl)methyl]amino}-5'-deoxyadenosine | 4 |
| 6D2 | 5'-{[(3S)-3-amino-3-carboxypropyl](3-carbamimidamidopropyl)amino}-5'-deoxyadenosine | 4 |
| 6D3 | (2S)-2-amino-4-[(3-{4-[(2S)-2-amino-2-carboxyethyl]-1H-1,2,3-triazol-1-yl}propyl){[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl}amino]butanoic acid (non-preferred name) | 4 |
| 6D5 | (2~{S})-4-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-(3-azidopropyl)amino]-2-azanyl-butanoic acid | 4 |